Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Atrial FibrillationStroke
Interventions
DEVICE

Catheter Ablation

Catheter Ablation is commonly performed with radiofrequency or cryotherapy to maintain a rhythm control strategy if patients can no longer tolerate their symptoms or are no longer controlled on AVNB or AAD. The procedure leads to significant symptom improvement even though there may be insignificant AF recurrence at one year. At Kansas City Heart Rhythm Institute, CA may be performed with radiofrequency ablation (Tactiflex Ablation Catheter, Abbott Cardiovascular, Minneapolis, MN) or pulsed field ablation (PulseSelectTM, Abbott Cardiovascular or FaraWaveTM, Boston Scientific, Marlborough, MA), performed with EnsiteX (Abbott Cardiovascular) or Carto3 (Biosense Webster, Irvine, CA) mapping software.

DRUG

Market-approved AVNB, OAC and AAD

Used per protocol for the duration of the trial.

Trial Locations (7)

64032

Research Medical Center Clinic, Kansas City

Research Medical Center, Kansas City

64057

Centerpoint Medical Center Clinic, Independence

Centerpoint Medical Center, Independence

66209

Menorah Medical Center, Overland Park

66211

Kansas City Heart Rhythm Institute - Roe Clinic, Overland Park

66215

Overland Park Regional Medical Center, Overland Park

All Listed Sponsors
lead

Kansas City Heart Rhythm Research Foundation

OTHER

NCT06783868 - Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control | Biotech Hunter | Biotech Hunter